Megan A Sylvester1, Heddwen L Brooks2,3. 1. Department of Physiology, College of Medicine, University of Arizona, 1656 E. Mabel St/Rm 417, P.O. Box 245218, Tucson, AZ, 85724-5218, USA. 2. Department of Physiology, College of Medicine, University of Arizona, 1656 E. Mabel St/Rm 417, P.O. Box 245218, Tucson, AZ, 85724-5218, USA. brooksh@email.arizona.edu. 3. Sarver Heart Center, University of Arizona, Tucson, AZ, USA. brooksh@email.arizona.edu.
Abstract
PURPOSE OF REVIEW: Despite enhanced screening and therapeutic management, hypertension remains the most prevalent chronic disease in the United States and the leading cause of heart disease, chronic kidney disease, and stroke in both men and women. It is widely accepted that hypertension is a pro-inflammatory disease and that the immune system plays a vital role in mediating hypertensive outcomes and end organ damage. Despite known discrepancies in the risk of hypertension development between men and women, preclinical models of immune-mediated hypertension were historically developed solely in male animals, leading to a lack of sex-specific clinical practice guidelines or therapeutic targets. RECENT FINDINGS: Following the NIH policy on the consideration of sex as a biological variable in 2015, significant advancements have been made into sex-specific disease mechanisms in inflammation and hypertension. This review article serves to critically evaluate recent advancements in the field of sex-specific immune-mediated hypertension.
PURPOSE OF REVIEW: Despite enhanced screening and therapeutic management, hypertension remains the most prevalent chronic disease in the United States and the leading cause of heart disease, chronic kidney disease, and stroke in both men and women. It is widely accepted that hypertension is a pro-inflammatory disease and that the immune system plays a vital role in mediating hypertensive outcomes and end organ damage. Despite known discrepancies in the risk of hypertension development between men and women, preclinical models of immune-mediated hypertension were historically developed solely in male animals, leading to a lack of sex-specific clinical practice guidelines or therapeutic targets. RECENT FINDINGS: Following the NIH policy on the consideration of sex as a biological variable in 2015, significant advancements have been made into sex-specific disease mechanisms in inflammation and hypertension. This review article serves to critically evaluate recent advancements in the field of sex-specific immune-mediated hypertension.
Entities:
Keywords:
Antigen presenting cells; Cytokine; Inflammasome; Menopause; Sex differences; T cells
Authors: Dennis P Pollow; Joshua A Uhlorn; Megan A Sylvester; Melissa J Romero-Aleshire; Jennifer L Uhrlaub; Merry L Lindsey; Janko Nikolich-Zugich; Heddwen L Brooks Journal: Am J Physiol Heart Circ Physiol Date: 2019-05-17 Impact factor: 4.733
Authors: Nikhil V Kamat; Salim R Thabet; Liang Xiao; Mohamed A Saleh; Annet Kirabo; Meena S Madhur; Eric Delpire; David G Harrison; Alicia A McDonough Journal: Hypertension Date: 2015-01-19 Impact factor: 10.190
Authors: Allison E Norlander; Mohamed A Saleh; Nikhil V Kamat; Benjamin Ko; Juan Gnecco; Linjue Zhu; Bethany L Dale; Yoichiro Iwakura; Robert S Hoover; Alicia A McDonough; Meena S Madhur Journal: Hypertension Date: 2016-05-02 Impact factor: 10.190
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison Journal: Hypertension Date: 2009-12-28 Impact factor: 10.190
Authors: Lia E Taylor; Ellen E Gillis; Jacqueline B Musall; Babak Baban; Jennifer C Sullivan Journal: Am J Physiol Heart Circ Physiol Date: 2018-09-21 Impact factor: 4.733
Authors: Jie Zhang; Larry Qu; Jin Wei; Shan Jiang; Lan Xu; Lei Wang; Feng Cheng; Kun Jiang; Jacentha Buggs; Ruisheng Liu Journal: Am J Physiol Renal Physiol Date: 2020-10-12
Authors: Janko Nikolich-Žugich; Christine M Bradshaw; Jennifer L Uhrlaub; Makiko Watanabe Journal: Curr Opin Virol Date: 2020-11-04 Impact factor: 7.090
Authors: Teresa A Milner; Natalina H Contoreggi; Fangmin Yu; Megan A Johnson; Gang Wang; Clara Woods; Sanoara Mazid; Tracey A Van Kempen; Elizabeth M Waters; Bruce S McEwen; Kenneth S Korach; Michael J Glass Journal: J Neurosci Date: 2021-05-03 Impact factor: 6.167
Authors: Rhian M Touyz; Francisco J Rios; Rhéure Alves-Lopes; Karla B Neves; Livia L Camargo; Augusto C Montezano Journal: Can J Cardiol Date: 2020-02-24 Impact factor: 5.223
Authors: Joshua A Uhlorn; Nathaniel A Husband; Melissa J Romero-Aleshire; Caitlin Moffett; Merry L Lindsey; Paul R Langlais; Heddwen L Brooks Journal: J Am Heart Assoc Date: 2021-01-07 Impact factor: 5.501